UK markets closed

APGE Oct 2024 75.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.90000.0000 (0.00%)
As of 09:30AM EDT. Market open.
Full screen
Previous close0.9000
Open0.9000
Bid0.0000
Ask3.0000
Strike75.00
Expiry date2024-10-18
Day's range0.9000 - 0.9000
Contract rangeN/A
Volume1
Open interest4
  • GlobeNewswire

    Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD

    SAN FRANCISCO and WALTHAM, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing differentiated biologics for the treatment of atopic dermatitis, chronic obstructive pulmonary disease (COPD) and other inflammatory and immunology (I&I) indications, today announced that Lisa Bollinger, MD, has been appointed to the company’s board of directors. Dr. Bollinger most recently served as Vice President, Regulatory Affairs, Glob

  • Simply Wall St.

    Here's Why We're Not Too Worried About Apogee Therapeutics' (NASDAQ:APGE) Cash Burn Situation

    Just because a business does not make any money, does not mean that the stock will go down. For example, although...

  • GlobeNewswire

    Apogee Therapeutics to Participate in Upcoming June Investor Conferences

    SAN FRANCISCO and WALTHAM, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing differentiated biologics for the treatment of atopic dermatitis, COPD, asthma and other inflammatory and immunology indications, today announced that members of management will participate at the following upcoming investor conferences: Jefferies Global Healthcare Conference Date: Thursday, June 6, 2024Time: 8:30 a.m. ET Goldman Sachs 45th